Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,814,974 papers from all fields of science
Search
Sign In
Create Free Account
vinflunine
Known as:
4'-Deoxy-20',20'-difluoro-C'-norvincaleukoblastine
A bi-fluorinated derivative of the semi-synthetic vinca alkaloid vinorelbine with antitubulin, antineoplastic, and antiangiogenic activities…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Narrower (1)
Javlor
Microtubule Process
NCIt Antineoplastic Agent Terminology
Vinflunine Ditartrate
analogs & derivatives
Broader (1)
Vinblastine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Recent advances in genitourinary tumors: A review focused on biology and systemic treatment.
A. González del Alba
,
J. Arranz
,
+13 authors
C. Suarez
Critical reviews in oncology/hematology
2017
Corpus ID: 21787926
Review
2012
Review
2012
Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer.
J. Cortés
,
A. Montero
,
S. Glück
Cancer Treatment Reviews
2012
Corpus ID: 8030142
2011
2011
Synthesis and study of a molecularly imprinted polymer for the specific extraction of indole alkaloids from Catharanthus roseus extracts.
C. Lopez
,
B. Claude
,
P. Morin
,
J. Max
,
R. Pena
,
J. Ribet
Analytica Chimica Acta
2011
Corpus ID: 7557820
Review
2011
Review
2011
Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid
F. Schutz
,
J. Bellmunt
,
J. Rosenberg
,
T. Choueiri
Expert Opinion on Drug Safety
2011
Corpus ID: 19234742
Introduction: Vinca alkaloid agents have been widely used in several different types of malignancies. However, cancer cells…
Expand
Review
2011
Review
2011
Therapeutic management of breast cancer in the elderly
S. Spazzapan
,
D. Crivellari
,
+4 authors
A. Veronesi
Expert Opinion on Pharmacotherapy
2011
Corpus ID: 20238253
Introduction: Over the last few decades, the population of developed countries has aged. Breast cancer is the most common cancer…
Expand
2008
2008
Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites
S. Honoré
,
A. Pagano
,
+5 authors
D. Braguer
Molecular Cancer Therapeutics
2008
Corpus ID: 22926521
The motile behavior of endothelial cells is a crucial event for neoangiogenesis. We previously showed that noncytotoxic…
Expand
2008
2008
Vinflunine in the treatment of bladder cancer
M. Bachner
,
M. D. De Santis
Therapeutics and Clinical Risk Management
2008
Corpus ID: 10326992
Vinflunine (VFL) is a third-generation bifluorinated semi-synthetic vinca alkaloid obtained by superacidic chemistry from its…
Expand
2007
2007
Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
A. Makarov
,
P. Tsvetkov
,
+6 authors
D. Lafitte
Biochemistry
2007
Corpus ID: 22788316
Vinca alkaloids vinblastine and vincristine and some of their derivatives such as vinorelbine are widely used in therapy of…
Expand
Highly Cited
2006
Highly Cited
2006
Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells.
B. Pourroy
,
S. Honoré
,
+4 authors
D. Braguer
Cancer Research
2006
Corpus ID: 2786240
Angiogenesis is a key event in tumor progression and metastasis. This complex process, which constitutes a potent target for…
Expand
2002
2002
Optimization of the separation of Vinca alkaloids by nonaqueous capillary electrophoresis.
Laetitia Barthe
,
J. Ribet
,
M. Pélissou
,
Marie-José Degude
,
J. Fahy
,
A. Duflos
Journal of Chromatography A
2002
Corpus ID: 20792459
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE